Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for STRATA Skin Sciences (SSKN) over the last 13 years, with Q3 2025 value amounting to -$20000.0.

  • STRATA Skin Sciences' Gains from Investment Securities changed N/A to -$20000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$83000.0, marking a year-over-year decrease of 10864.58%. This contributed to the annual value of $977000.0 for FY2024, which is 145694.44% up from last year.
  • STRATA Skin Sciences' Gains from Investment Securities amounted to -$20000.0 in Q3 2025.
  • In the past 5 years, STRATA Skin Sciences' Gains from Investment Securities registered a high of $6.9 million during Q1 2021, and its lowest value of -$67000.0 during Q4 2021.
  • Its 5-year average for Gains from Investment Securities is $1.0 million, with a median of -$17500.0 in 2022.
  • Data for STRATA Skin Sciences' Gains from Investment Securities shows a peak YoY increase of 3654988.42% (in 2021) and a maximum YoY decrease of 660000.0% (in 2021) over the last 5 years.
  • STRATA Skin Sciences' Gains from Investment Securities (Quarter) stood at -$67000.0 in 2021, then soared by 74.63% to -$17000.0 in 2022, then changed by 0.0% to -$17000.0 in 2023, then skyrocketed by 5847.06% to $977000.0 in 2024, then tumbled by 102.05% to -$20000.0 in 2025.
  • Its Gains from Investment Securities stands at -$20000.0 for Q3 2025, versus -$29000.0 for Q2 2025 and -$34000.0 for Q1 2025.